Search research articles
Contact Us
Filters
Showing results (51-60 of 125) with videos related to
Page
of 13
Sort By:
Elife
|
September 2, 2015
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
Diego Acosta-Alvear, Min Y Cho, Thomas Wild, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 5, 2021
Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy
Marion Eveillard, Neha Korde, Amanda Ciardiello, et al.
Leukemia & Lymphoma
|
May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
Hani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
The Journal of Molecular Diagnostics : JMD
|
October 5, 2015
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression
Weixin Wang, Meghan Corrigan-Cummins, Emily A Barber, et al.
Scientific Reports
|
March 2, 2021
Oncologic immunomodulatory agents in patients with cancer and COVID-19
Justin Jee, Aaron J Stonestrom, Sean Devlin, et al.
Blood
|
March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Nikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Leukemia & Lymphoma
|
June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach
Oscar B Lahoud, Heather Landau, James Nguyen, et al.
Plos One
|
November 2, 2018
Dietary intake is associated with risk of multiple myeloma and its precursor disease
Marianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
Leukemia Research
|
January 28, 2014
Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases
Prashant R Tembhare, Constance M Yuan, David Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 125) with videos related to
Sort By:
Page
of 13
Elife
|
September 2, 2015
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
Diego Acosta-Alvear, Min Y Cho, Thomas Wild, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 5, 2021
Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy
Marion Eveillard, Neha Korde, Amanda Ciardiello, et al.
Leukemia & Lymphoma
|
May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
Hani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
The Journal of Molecular Diagnostics : JMD
|
October 5, 2015
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression
Weixin Wang, Meghan Corrigan-Cummins, Emily A Barber, et al.
Scientific Reports
|
March 2, 2021
Oncologic immunomodulatory agents in patients with cancer and COVID-19
Justin Jee, Aaron J Stonestrom, Sean Devlin, et al.
Blood
|
March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Nikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Leukemia & Lymphoma
|
June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach
Oscar B Lahoud, Heather Landau, James Nguyen, et al.
Plos One
|
November 2, 2018
Dietary intake is associated with risk of multiple myeloma and its precursor disease
Marianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
Leukemia Research
|
January 28, 2014
Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases
Prashant R Tembhare, Constance M Yuan, David Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Page
of 13